136 related articles for article (PubMed ID: 36583462)
21. Comparative Assessment of Off-label and Unlicensed Drug Prescriptions in Children: FDA Versus ANSM Guidelines.
Berdkan S; Rabbaa L; Hajj A; Eid B; Jabbour H; Osta NE; Karam L; Khabbaz LR
Clin Ther; 2016 Aug; 38(8):1833-44. PubMed ID: 27392716
[TBL] [Abstract][Full Text] [Related]
22. Off-label use of psychotropic drugs in a Swiss paediatric service: similar results from two different cohort studies.
Feka A; Di Paolo ER; Pauchard JY; Mariguesa A; Gehri M; Sadeghipour F
Swiss Med Wkly; 2022 Jan; 152():w30124. PubMed ID: 35147399
[TBL] [Abstract][Full Text] [Related]
23. Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.
Pratico AD; Longo L; Mansueto S; Gozzo L; Barberi I; Tiralongo V; Salvo V; Falsaperla R; Vitaliti G; La Rosa M; Leonardi S; Rotondo A; Avola N; Sgarlata D; Damiano A; Tirantello M; Anzelmo G; Cipolla D; Rizzo A; Russo A; Ruggieri M; Salomone S; Drago F
Curr Drug Saf; 2018; 13(3):200-207. PubMed ID: 29921210
[TBL] [Abstract][Full Text] [Related]
24. Safety of Off-Label Pharmacological Treatment in Pediatric Neuropsychiatric Disorders: A Global Perspective From an Observational Study at an Italian Third Level Children's Hospital.
Giurin MS; Trojniak MP; Arbo A; Carrozzi M; Abbracciavento G; Monasta L; Zanus C
Front Pharmacol; 2022; 13():837692. PubMed ID: 35496268
[No Abstract] [Full Text] [Related]
25. Off-label antibiotic use in a specialized children care hospital in Punjab, Pakistan: Findings and implications.
Hafeez M; Saleem Z; Bukhari NA; Hussain K; Shamim R; Hussain A; Bukhari NI
J Infect Dev Ctries; 2020 May; 14(5):540-544. PubMed ID: 32525842
[TBL] [Abstract][Full Text] [Related]
26. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
[TBL] [Abstract][Full Text] [Related]
27. Compassionate drug uses in Italy. Analysis of regional and local diffusion.
Pilunni D; Navarra P
Ann Ist Super Sanita; 2023; 59(1):43-50. PubMed ID: 36974704
[TBL] [Abstract][Full Text] [Related]
28. Off-label prescribing in pediatric outpatients.
Palmaro A; Bissuel R; Renaud N; Durrieu G; Escourrou B; Oustric S; Montastruc JL; Lapeyre-Mestre M
Pediatrics; 2015 Jan; 135(1):49-58. PubMed ID: 25511119
[TBL] [Abstract][Full Text] [Related]
29. Adverse drug reactions associated with off-label use of ketorolac, with particular focus on elderly patients. An analysis of the Italian pharmacovigilance database and a population based study.
Viola E; Trifirò G; Ingrasciotta Y; Sottosanti L; Tari M; Giorgianni F; Moretti U; Leone R
Expert Opin Drug Saf; 2016 Dec; 15(sup2):61-67. PubMed ID: 27875919
[TBL] [Abstract][Full Text] [Related]
30. Prescription Pattern Monitoring and Off-label Use of Medicines in the Pediatric Department at Tertiary Care Teaching Hospital.
Pandey S; Yadav CK; Ghimire P; Shrestha AC
Kathmandu Univ Med J (KUMJ); 2020 Oct.-Dec.; 18(72):367-371. PubMed ID: 34165093
[TBL] [Abstract][Full Text] [Related]
31. Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada.
Judd S; Revon-Riviere G; Grover SA; Deyell RJ; Vanan MI; Lewis VA; Pecheux L; Zorzi AP; Goudie C; Santiago R; Tran TH; Abbott LS; Brossard J; Moorehead P; Alvi S; Portwine C; Denburg A; Whitlock JA; Cohen-Gogo S; Morgenstern DA
Cancer Med; 2024 Feb; 13(3):e7033. PubMed ID: 38400668
[TBL] [Abstract][Full Text] [Related]
32. In-label and off-label use of respiratory drugs in the Italian paediatric population.
Baiardi P; Ceci A; Felisi M; Cantarutti L; Girotto S; Sturkenboom M; Baraldi E
Acta Paediatr; 2010 Apr; 99(4):544-9. PubMed ID: 20105140
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian Regulatory Agency versus FDA.
Borges AP; Campos MS; Pereira LR
Int J Clin Pharm; 2013 Jun; 35(3):425-31. PubMed ID: 23430533
[TBL] [Abstract][Full Text] [Related]
34. Use of off-label nephrology-related drugs in hospitalized pediatric patients: a retrospective study.
Yasinta M; Che RC; Hu CY; Du XH; Ding GX; Huang SM; Chen Y; Zhang AH
World J Pediatr; 2016 May; 12(2):236-42. PubMed ID: 26684307
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of off-label drug uses in hospitals: a multicentric prospective study.
Danés I; Agustí A; Vallano A; Alerany C; Martínez J; Bosch JA; Ferrer A; Gratacós L; Pérez A; Olmo M; Marron SM; Valderrama A; Bonafont X
Eur J Clin Pharmacol; 2014 Nov; 70(11):1385-93. PubMed ID: 25196202
[TBL] [Abstract][Full Text] [Related]
36. [Off-label drugs in childhood psoriasis].
Mahé E; Corgibet F; Maccari F; Hadj-Rabia S; Phan C; Ruer-Mulard M; Boralévi F; Barbarot S; Bursztejn AC; Lahfa M; Severino-Freire M; Aubin F; Barthélémy H; Amy de la Bretêque M; Beauchet A; ; ; ;
Ann Dermatol Venereol; 2020; 147(6-7):429-438. PubMed ID: 32299624
[TBL] [Abstract][Full Text] [Related]
37. Off-label and unlicensed drug use in a pediatric intensive care unit of a tertiary care Spanish hospital. A descriptive study.
Camacho Arroyo MT; Rivas Paterna AB; Meneses Monroy A; Cabrera García L; Blázquez González P; Mancebo Salas N; Rodríguez Leal L; Vargas Castrillón E
Arch Argent Pediatr; 2023 Feb; 121(1):e202102550. PubMed ID: 36194689
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Unlicensed and Off-Label Use of Antipsychotics Prescribed to Child and Adolescent Psychiatric Outpatients for Treatment of Mental and Behavioral Disorders with Different Guidelines: The China Food and Drug Administration Versus the FDA.
Zhu X; Hu J; Sun B; Deng S; Wen Y; Chen W; Qiu C; Shang D; Zhang M
J Child Adolesc Psychopharmacol; 2018 Apr; 28(3):216-224. PubMed ID: 29336603
[TBL] [Abstract][Full Text] [Related]
39. Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.
Wong J; Motulsky A; Abrahamowicz M; Eguale T; Buckeridge DL; Tamblyn R
BMJ; 2017 Feb; 356():j603. PubMed ID: 28228380
[No Abstract] [Full Text] [Related]
40. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation.
Lindell-Osuagwu L; Hakkarainen M; Sepponen K; Vainio K; Naaranlahti T; Kokki H
J Clin Pharm Ther; 2014 Apr; 39(2):144-53. PubMed ID: 24329556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
